The Hindu·2 min read·medium
Sun Pharma gets favourable verdict in antitrust-litigation in U.S.
T
The Hindu Bureau
✦AI Summary
Sun Pharmaceutical Industries has won an antitrust lawsuit in the U.S. regarding a 2008 patent settlement for the generic drug Lipitor. The appellate court affirmed a lower court's decision to grant summary judgment in favor of the company.
Sun Pharmaceutical Industries on Monday (August 17, 2026) said an appellate court in the United States has passed a judgment in favour of the company and its subsidiaries in the antitrust litigation, in the U.S., relating to a 2008 patent litigation settlement agreement with Pfizer concerning generic Lipitor (Atorvastatin).
businesshealtheconomy
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in